GTC
ALT icon

Ghost Tree Capital’s Altimmune ALT Stock Holding History

Ghost Tree Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250,000
Closed -$2.54M – 65
2024
Q1 		$2.54M Buy
+250,000
New +$2.54M 0.7% 47
2022
Q4 		– Sell
-435,000
Closed -$5.55M – 36
2022
Q3 		$5.55M Buy
+435,000
New +$6.42M 1.56% 23
2020
Q4 		– Sell
-200,000
Closed -$2.64M – 47
2020
Q3 		$2.64M Buy
200,000
+50,000
+33% +$1,000K 0.76% 34
2020
Q2 		$1.61M Buy
+150,000
New +$824K 0.42% 39

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ghost Tree Capital's ALT Position: Q2 2024 in Review

Ghost Tree Capital sold out of Altimmune (ALT) in Q2 2024, closing a stake of 250,000 shares — an estimated $2.54M sold.

Ghost Tree Capital first reported a position in ALT in Q2 2020 and held it in 4 quarters. The position peaked at $5.55M in Q3 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q2 2024.

  • Ghost Tree Capital reported no remaining Altimmune position as of Q2 2024 after selling out during the quarter.
  • Ghost Tree Capital sold 250,000 Altimmune shares in Q2 2024, an estimated $2.54M.
  • Ghost Tree Capital first reported a position in Altimmune in Q2 2020 and held it in 4 quarters.
  • Ghost Tree Capital's Altimmune position peaked at $5.55M in Q3 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q2 2024.

Based on Ghost Tree Capital's 13F filing for Q2 2024, filed 14 Aug 2024.